The Predictive-Toxicology Evaluation (PTE) project conducts collaborative experiments that subject the performance of predictive-toxicology (PT) methods to 
equivocal; EE, equivocal evidence; EQV, equivocal overall classification; LOE, level of evidence; N, none; NE, no evidence; NEG, negative overall classification; NIEHS, National Institute of Environmental Health Sciences; NP, no prediction made; NTP, U.S. National Toxicology Program; P, positive; POS, positive overall classification; PT, predictive-toxicology; PTE, Predictive-Toxicology Evaluation; PTE-1/PTE-2, first or second PTE experiment; QSAR, quantitative structure-activity relationship; SE, some evidence; STT, short-term tests; TR, Technical Report; W+, weakly positive; W+/U, weak positive or uncertain probability for being positive. chemical, inorganic compound, mineral, polymer, or mixture.
Level ofevidence (LOE). NTP assigns a LOE to each sex-species, chemical carcinogenicity experiment, as defined in each NTP Technical Report (TR). These are CE, clear evidence; SE, some evidence; EE, equivocal evidence; NE, no evidence; for older studies, they are P, positive; E, equivocal; and N, none.
Overall LOE. The LOE assigned to each sex-species experiment, combined with a classification for the overall bioassay study, using the following algorithm: a) If the LOE for one or more of the experiments is CE, SE, or P, then the overall classification is positive (POS); b) If the LOE for all of the experiments is NE or E, then the overall classification is negative (NEG); c) If the LOE for one or more of the experiments is EE or E and the LOE for the other experiments is NE or N, then the overall classification is equivocal (EQV); d) Experiments classified as inadequate study (IS) are given no consideration in arriving at the overall LOE classification.
Need for PredictiveToxicology Models
The NTP conducts standardized chemical bioassays in rodents to identify and characterize exposures to substances that may be associated with carcinogenic or other toxicological effects on human health (1). Current regulations require that safety testing be performed in connection with the development of new chemicals or new uses of known chemicals. However, before the advent of such regulations, more chemicals came into use than can ever be tested using conventional methods. At the present time, society in general and the discipline of toxicology in particular, face the parallel tasks of performing safety evaluations that support the development of new chemical uses before human exposures are permitted and assessing the potential hazard posed by exposures to chemicals that lack safety evaluations. This situation creates an urgent need to develop PT models that * generate predictions of known reliability or are accompanied by confidence level estimate * identify hazardous-chemical exposures more rapidly at a lower cost than current procedures * apply to all types of test articles, includ- ing organic, inorganic, polymeric, mineral, and mixtures * provide information that supports sound decision making for the effective and efficient management of laboratory animal testing that is still needed by regulatory and chemical development programs * refine and reduce reliance on the use of large numbers of laboratory animals in the conduct of chembioassays * accelerate the performance of risk assessments and the conduct of research and development programs.
Goals of Predictive-Toxicology Research
The development of models that reliably identify the hazard for untested chemical substances, of any type, using attribute values that can be computed or obtained with minimum testing time and cost is widely recognized to be the most immediate goal of PT research.
The return of information and overall value of an NTP bioassay increases when it is included in a PTE experiment because each prediction made about its outcome represents an additional hypothesis that is tested by the bioassay. Thus, in addition to characterizing the toxicity of individual chemicals (i.e., identify hazard), standardized bioassay tests also stimulate PT research by providing both learning sets for the development of models and the means to subject model performance to hypothesis testing.
Another, less perceived, aspect of PT research has potential value that far exceeds the generation of reliable predictions per se. Some PT models are based on patternrecognition analysis of a learning set (2) (3) (4) (5) (6) (7) (8) (9) , it is complementary to and synergistic with the conduct of mechanistic studies.
The discovery aspect of PT research may also lead to an important refinement in the use of quantitative structure-activity-relationship (QSAR) models. A classical, extra thermodynamic QSAR approach (10, 11) can only be applied to model chemical bioactivities governed by a unique mechanistic pathway, i.e., where chemical bioactivity is controlled by a single ratelimiting step. This limits the legitimate application of each different QSAR model, to untested chemicals that can be expected to be processed under the control of the same mechanism for which the QSAR was developed. When faced with selecting a QSAR model to study the mechanistic behavior of an untested chemical, there is no legitimate way to determine which of the many available might apply most appropriately. This uncertainty would be eliminated by the development of PT models that predict not only the activity expected for an untested chemical, but also indicate the mechanistic pathway that governs it. Thus, the output of such PT models would serve to guide the selection of QSAR models that may be used legitimately to elucidate mechanistic details and gain understanding that fosters better interpretation of the activity predicted.
Evaluation of PredictiveToxicology Models
The advantages offered by PT research are clear; however, difficult problems remain that involve both model development and acceptance issues (12) . A recent, definitive study of difficulties associated with the model confirmation problem (9) This important publication explains why it is impossible to establish confidence limits on boundaries of the feature space spanned by a PT model, which might otherwise be used to guide and restrict its application to legitimate cases. Also, because the boundaries of PT models are inexact, the legitimate range of application for PT models will always be uncertain, to some extent. The complex nature of the model confirmation problem presents a perplexing challenge to both developers and potential users; to gain acceptance and fulfill their promise, PT models must demonstrate performance accuracy that earns the confidence of would-be users.
PT-model evaluations based on crossvalidation techniques (13) The "Tox testing" module in Figure 1 represents the engine that drives learning in toxicology, because it is the primary source of phenomenological observations, the foundation for learning in science. Standardized toxicity testing fosters the healthy growth and maturation of this relatively young discipline (12) by providing learning sets that support the development of models and theories. It is important to use learning sets that include a sufficient number and variety of classified cases to adequately represent the uncertain number of multifactorial, mechanistic pathways that are associated with a complex toxicity endpoint like chemical carcinogenicity. Figure 2 illustrates how a fully evaluated and confirmed PT 
